MONGIORGI, SARA
MONGIORGI, SARA
DIPARTIMENTO DI SCIENZE BIOMEDICHE E NEUROMOTORIE
Personale tecnico amm.vo
A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes
2023 Mongiorgi, Sara; De Stefano, Alessia; Ratti, Stefano; Indio, Valentina; Astolfi, Annalisa; Casalin, Irene; Pellagatti, Andrea; Paolini, Stefania; Parisi, Sarah; Cavo, Michele; Pession, Andrea; McCubrey, James A; Suh, Pann-Ghill; Manzoli, Lucia; Boultwood, Jacqueline; Finelli, Carlo; Cocco, Lucio; Follo, Matilde Y
Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients
2012 Follo M.Y.; Mongiorgi S.; Clissa C.; Paolini S.; Martinelli G.; Martelli A.M.; Fioravanti G.; Manzoli L.; Finelli C.; Cocco L.
An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes
2015 Cocco, Lucio; Finelli, Carlo; Mongiorgi, Sara; Clissa, Cristina; Russo, Domenico; Bosi, Costanza; Quaranta, Marilisa; Malagola, Michele; Parisi, Sarah; Stanzani, Marta; Ramazzotti, Giulia; Mariani, Giulia A.; Billi, Anna Maria; Manzoli, Lucia; Follo, Matilde Y.
AZACITIDINE FOR HIGH RISK MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE EVALUATION OF TWO DIFFERENT DOSING SCHEDULES
2011 Finelli C; Clissa C; Follo MY; Curti A;Paolini S; Papayannidis C; Mongiorgi S; Parisi S; Bosi C; Manzoli L; Martinelli G; Cocco L; Baccarani M
AZACITIDINE IN HIGH AND LOW RISK MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF 57 PATIENTS TREATED WITH 4 DIFFERENT THERAPEUTIC REGIMENS
2013 Clissa C;Finelli C;Follo MY; Stanzani M; Curti A; Paolini S; Papayannidis C; Mongiorgi S; Parisi S; Abbenante MC; Bosi C; Manzoli L; Martinelli G; Cocco L; Cavo M
Azacitidine in Myelodysplastic Syndromes: Multicenter Retrospective Study of 34 Long-Responder Patients
2012 Carlo Finelli; Cristina Clissa; Maria Teresa Voso; Maria Antonietta Aloe Spiriti; Massimo Breccia; Gianluca Gaidano; Monica Crugnola; Maria Benedetta Giannini; Costanza Bosi; Virginia Naso; Matilde Y Follo; Sara Mongiorgi; Giovanni Martinelli; Lucio Cocco; Michele Baccarani
AZACITIDINE IN MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF LONG-RESPONDER PATIENTS
2012 Clissa C; Finelli C; Follo MY; Curti A; Paolini S; Papayannidis C; Mongiorgi S; Parisi S; Abbenante MC; Bosi C; Manzoli L; Martinelli G; Cocco L; Baccarani M
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes
2021 Ratti S.; Rusciano I.; Mongiorgi S.; Owusu Obeng E.; Cappellini A.; Teti G.; Falconi M.; Talozzi L.; Capellari S.; Bartoletti-Stella A.; Guaraldi P.; Cortelli P.; Suh P.-G.; Cocco L.; Manzoli L.; Ramazzotti G.
Clinical and molecular insights in erythropoiesis regulation of signal transduction pathways in myelodysplastic syndromes and β-thalassemia
2021 Parisi S.; Finelli C.; Fazio A.; De Stefano A.; Mongiorgi S.; Ratti S.; Cappellini A.; Billi A.M.; Cocco L.; Follo M.Y.; Manzoli L.
Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes
2016 Finelli, Carlo; Follo, Matilde Y; Stanzani, Marta; Parisi, Sarah; Clissa, Cristina; Mongiorgi, Sara; Barraco, Marilena; Cocco, Lucio
CLONAL ACTIVATION OF AKT IN LOW-RISK MDS PATIENTS WITH DEL(5Q) TREATED WITH LENALIDOMIDE
2013 Follo MY; Clissa C; Mongiorgi S; Stoyanova M; Paolini S; Quaranta M; Stanzani M; Martinelli G; Manzoli L; Cocco L; Finelli C
Clonal activation of Akt in low-risk MDS patients with del(5q) treated with lenalidomide
2013 M.Y. Follo; S. Mongiorgi; C. Clissa; M. Stoyanova; S. Paolini; M. Quaranta; G. Martinelli; L. Manzoli; C. Cocco; C. Finelli
Clonal Effect Of Lenalidomide On Akt Activation In Low-Risk MDS Patients With Del(5q)
2013 Matilde Y Follo; Carlo Finelli; Cristina Clissa; Sara Mongiorgi; Carmen Baldazzi; Marta Stanzani; Michele Baccarani; Lucio Cocco
Current therapy and new drugs: A road to personalized treatment of myelodysplastic syndromes
2018 Parisi S.; Ratti S.; Mongiorgi S.; Suh P.-G.; Manzoli L.; McCubrey J.A.; Cocco L.; Follo M.Y.; Finelli C.
DIFFERENTIAL EFFECT OF LENALIDOMIDE ON INDUCTION OF INOSITIDE-DEPENDENT ERYTHROPOIESIS AND CELL CYCLE IN MYELODYSPLASTIC SYNDROMES
2014 Follo, My; Mongiorgi, S; Clissa, C; Stanzani, M; Poli, A; Lonetti, A; Cappellini, A; Manzoli, L; Cocco L, 1; Finelli, C
Early Increase of Phospholipase Cbeta1 (PI-PLCbeta1) Gene Expression Predicts Azacitidine Responsiveness in MDS Patients
2012 Matilde Y Follo; Carlo Finelli; Cristina Clissa; Sara Mongiorgi; Carla Filì; Costanza Bosi; Marilisa Quaranta; Stefania Paolini; Anna Maria Billi; Marco Gobbi; Michele Baccarani; Domenico Russo; Giovanni Martinelli; Lucia Manzoli; Lucio Cocco
Effect of azacitidine on inositide-dependent signalling pathways in low-risk MDS patients
2011 M.Y. Follo; S. Mongiorgi; C. Clissa; C. Filì; C. Colombi; M. Baccarani; G. Martinelli; M. Gobbi; L. Manzoli; D. Russo; C. Finelli; L. Cocco
Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients.
2009 Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Francesca Chiarini; Stefania Paolini; Michele Baccarani; Giovanni Martinelli; Lucia Manzoli; Alberto M. Martelli; Carlo Finelli; Lucio Cocco
EFFECT OF LENALIDOMIDE ON INOSITIDE-DEPENDENT SIGNAL TRANSDUCTION PATHWAYS
2011 Follo MY;Mongiorgi S; Clissa C; Baccarani M; Paolini S; Martinelli G; Manzoli L; Finelli C; Cocco L
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients
2011 Matilde Y Follo; Cristina Clissa; Sara Mongiorgi; Francesca Chiarini; Michele Baccarani; Giovanni Martinelli; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes | Mongiorgi, Sara; De Stefano, Alessia; Ratti, Stefano; Indio, Valentina; Astolfi, Annalisa; Casali...n, Irene; Pellagatti, Andrea; Paolini, Stefania; Parisi, Sarah; Cavo, Michele; Pession, Andrea; McCubrey, James A; Suh, Pann-Ghill; Manzoli, Lucia; Boultwood, Jacqueline; Finelli, Carlo; Cocco, Lucio; Follo, Matilde Y | 2023-01-01 | CLINICAL EPIGENETICS | - | 1.01 Articolo in rivista | - |
Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients | Follo M.Y.; Mongiorgi S.; Clissa C.; Paolini S.; Martinelli G.; Martelli A.M.; Fioravanti G.; Man...zoli L.; Finelli C.; Cocco L. | 2012-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes | Cocco, Lucio; Finelli, Carlo; Mongiorgi, Sara; Clissa, Cristina; Russo, Domenico; Bosi, Costanza;... Quaranta, Marilisa; Malagola, Michele; Parisi, Sarah; Stanzani, Marta; Ramazzotti, Giulia; Mariani, Giulia A.; Billi, Anna Maria; Manzoli, Lucia; Follo, Matilde Y. | 2015-01-01 | JOURNAL OF LEUKOCYTE BIOLOGY | - | 1.01 Articolo in rivista | - |
AZACITIDINE FOR HIGH RISK MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE EVALUATION OF TWO DIFFERENT DOSING SCHEDULES |
Finelli C; Clissa C; Follo MY; Curti A;Paolini S; Papayannidis C; Mongiorgi S; Parisi S; Bosi C; ...Manzoli L; Martinelli G; Cocco L; Baccarani M |
2011-01-01 | HAEMATOLOGICA | - | 4.01 Contributo in Atti di convegno | - |
AZACITIDINE IN HIGH AND LOW RISK MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF 57 PATIENTS TREATED WITH 4 DIFFERENT THERAPEUTIC REGIMENS |
Clissa C;Finelli C;Follo MY; Stanzani M; Curti A; Paolini S; Papayannidis C; Mongiorgi S; Parisi ...S; Abbenante MC; Bosi C; Manzoli L; Martinelli G; Cocco L; Cavo M |
2013-01-01 | HAEMATOLOGICA | - | 4.01 Contributo in Atti di convegno | - |
Azacitidine in Myelodysplastic Syndromes: Multicenter Retrospective Study of 34 Long-Responder Patients | Carlo Finelli; Cristina Clissa; Maria Teresa Voso; Maria Antonietta Aloe Spiriti; Massimo Breccia...; Gianluca Gaidano; Monica Crugnola; Maria Benedetta Giannini; Costanza Bosi; Virginia Naso; Matilde Y Follo; Sara Mongiorgi; Giovanni Martinelli; Lucio Cocco; Michele Baccarani | 2012-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
AZACITIDINE IN MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF LONG-RESPONDER PATIENTS |
Clissa C; Finelli C; Follo MY; Curti A; Paolini S; Papayannidis C; Mongiorgi S; Parisi S; Abbenan...te MC; Bosi C; Manzoli L; Martinelli G; Cocco L; Baccarani M |
2012-01-01 | HAEMATOLOGICA | - | 4.01 Contributo in Atti di convegno | - |
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes | Ratti S.; Rusciano I.; Mongiorgi S.; Owusu Obeng E.; Cappellini A.; Teti G.; Falconi M.; Talozzi ...L.; Capellari S.; Bartoletti-Stella A.; Guaraldi P.; Cortelli P.; Suh P.-G.; Cocco L.; Manzoli L.; Ramazzotti G. | 2021-01-01 | CELLULAR AND MOLECULAR LIFE SCIENCES | - | 1.01 Articolo in rivista | s00018-020-03661-1.pdf |
Clinical and molecular insights in erythropoiesis regulation of signal transduction pathways in myelodysplastic syndromes and β-thalassemia | Parisi S.; Finelli C.; Fazio A.; De Stefano A.; Mongiorgi S.; Ratti S.; Cappellini A.; Billi A.M....; Cocco L.; Follo M.Y.; Manzoli L. | 2021-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | ijms-22-00827-v2.pdf |
Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes | Finelli, Carlo; Follo, Matilde Y; Stanzani, Marta; Parisi, Sarah; Clissa, Cristina; Mongiorgi, Sa...ra; Barraco, Marilena; Cocco, Lucio | 2016-01-01 | CURRENT PHARMACEUTICAL DESIGN | - | 1.01 Articolo in rivista | - |
CLONAL ACTIVATION OF AKT IN LOW-RISK MDS PATIENTS WITH DEL(5Q) TREATED WITH LENALIDOMIDE |
Follo MY; Clissa C; Mongiorgi S; Stoyanova M; Paolini S; Quaranta M; Stanzani M; Martinelli G; Ma...nzoli L; Cocco L; Finelli C |
2013-01-01 | HAEMATOLOGICA | - | 4.01 Contributo in Atti di convegno | - |
Clonal activation of Akt in low-risk MDS patients with del(5q) treated with lenalidomide | M.Y. Follo; S. Mongiorgi; C. Clissa; M. Stoyanova; S. Paolini; M. Quaranta; G. Martinelli; L. Man...zoli; C. Cocco; C. Finelli | 2013-01-01 | LEUKEMIA RESEARCH | - | 4.01 Contributo in Atti di convegno | - |
Clonal Effect Of Lenalidomide On Akt Activation In Low-Risk MDS Patients With Del(5q) | Matilde Y Follo; Carlo Finelli; Cristina Clissa; Sara Mongiorgi; Carmen Baldazzi; Marta Stanzani;... Michele Baccarani; Lucio Cocco | 2013-01-01 | BLOOD | - | 4.01 Contributo in Atti di convegno | - |
Current therapy and new drugs: A road to personalized treatment of myelodysplastic syndromes | Parisi S.; Ratti S.; Mongiorgi S.; Suh P.-G.; Manzoli L.; McCubrey J.A.; Cocco L.; Follo M.Y.; Fi...nelli C. | 2018-01-01 | EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT | - | 1.01 Articolo in rivista | - |
DIFFERENTIAL EFFECT OF LENALIDOMIDE ON INDUCTION OF INOSITIDE-DEPENDENT ERYTHROPOIESIS AND CELL CYCLE IN MYELODYSPLASTIC SYNDROMES | Follo, My; Mongiorgi, S; Clissa, C; Stanzani, M; Poli, A; Lonetti, A; Cappellini, A; Manzoli, L; ...Cocco L, 1; Finelli, C | 2014-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
Early Increase of Phospholipase Cbeta1 (PI-PLCbeta1) Gene Expression Predicts Azacitidine Responsiveness in MDS Patients | Matilde Y Follo; Carlo Finelli; Cristina Clissa; Sara Mongiorgi; Carla Filì; Costanza Bosi; Maril...isa Quaranta; Stefania Paolini; Anna Maria Billi; Marco Gobbi; Michele Baccarani; Domenico Russo; Giovanni Martinelli; Lucia Manzoli; Lucio Cocco | 2012-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
Effect of azacitidine on inositide-dependent signalling pathways in low-risk MDS patients | M.Y. Follo; S. Mongiorgi; C. Clissa; C. Filì; C. Colombi; M. Baccarani; G. Martinelli; M. Gobbi; ...L. Manzoli; D. Russo; C. Finelli; L. Cocco | 2011-01-01 | LEUKEMIA RESEARCH | - | 4.01 Contributo in Atti di convegno | - |
Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients. | Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Francesca Chiarini; Stefania Paolini; Michele B...accarani; Giovanni Martinelli; Lucia Manzoli; Alberto M. Martelli; Carlo Finelli; Lucio Cocco | 2009-01-01 | BLOOD | - | 4.01 Contributo in Atti di convegno | - |
EFFECT OF LENALIDOMIDE ON INOSITIDE-DEPENDENT SIGNAL TRANSDUCTION PATHWAYS |
Follo MY;Mongiorgi S; Clissa C; Baccarani M; Paolini S; Martinelli G; Manzoli L; Finelli C; Cocco L |
2011-01-01 | HAEMATOLOGICA | - | 4.01 Contributo in Atti di convegno | - |
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients | Matilde Y Follo; Cristina Clissa; Sara Mongiorgi; Francesca Chiarini; Michele Baccarani; Giovanni... Martinelli; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco | 2011-01-01 | BLOOD | - | 4.01 Contributo in Atti di convegno | - |